149 related articles for article (PubMed ID: 10604283)
1. Enhanced absorption of oral furosemide by bile juice in rats.
Kim EJ; Han KS; Lee MG
Res Commun Mol Pathol Pharmacol; 1999; 104(1):107-10. PubMed ID: 10604283
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
Lee MG; Chiou WL
Drug Metab Dispos; 1998 May; 26(5):401-7. PubMed ID: 9571221
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal first-pass effect of furosemide in rats.
Kim EJ; Han KS; Lee MG
J Pharm Pharmacol; 2000 Nov; 52(11):1337-43. PubMed ID: 11186241
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic changes of furosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
Park JH; Lee WI; Yoon WH; Park YD; Lee JS; Lee MG
Biopharm Drug Dispos; 1998 Sep; 19(6):357-64. PubMed ID: 9737816
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.
Lee WI; Yoon WH; Shin WG; Song IS; Lee MG
Biopharm Drug Dispos; 1997 Dec; 18(9):753-67. PubMed ID: 9429740
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence evaluation of two brands of furosemide 40 mg tablets (Salurin and Lasix) in healthy human volunteers.
Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
Biopharm Drug Dispos; 2003 Sep; 24(6):245-9. PubMed ID: 12973821
[TBL] [Abstract][Full Text] [Related]
7. Effect of route of administration on the relative efficacy and potency of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol HCl (MK447) and furosemide.
Johnston PA; Leszczynska K; Yochim C; Kau ST
Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):481-6. PubMed ID: 2087148
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites.
Akiyama Y; Nagahara N; Nara E; Kitano M; Iwasa S; Yamamoto I; Azuma J; Ogawa Y
J Pharm Pharmacol; 1998 Feb; 50(2):159-66. PubMed ID: 9530983
[TBL] [Abstract][Full Text] [Related]
9. Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
Kim SH; Park KJ; Yoon WH; Lee JW; Kim ND; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):233-44. PubMed ID: 8832915
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition.
Shim HJ; Kim YC; Lee JH; Ahn BO; Kwon JW; Kim WB; Lee I; Lee MG
J Pharm Pharmacol; 2004 Dec; 56(12):1543-50. PubMed ID: 15563761
[TBL] [Abstract][Full Text] [Related]
11. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
Yang KH; Choi YH; Lee U; Lee JH; Lee MG
J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
[TBL] [Abstract][Full Text] [Related]
12. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
13. Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Bae SK; Lee SJ; Kwon JW; Kim WB; Lee MG
J Pharm Pharmacol; 2004 May; 56(5):635-42. PubMed ID: 15142341
[TBL] [Abstract][Full Text] [Related]
14. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
Wang S; Sun M; Ping Q
Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.
Lee JH; Kim YC; Kwon JW; Kim WB; Lee MG
Int J Pharm; 2005 May; 296(1-2):94-102. PubMed ID: 15885460
[TBL] [Abstract][Full Text] [Related]
18. Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.
Dirikolu L; Lehner AF; Hughes C; Karpiesiuk W; Camargo FC; Harkins JD; Woods WE; Bosken JM; Boyles J; Troppmann A; Fisher M; Tobin T
Vet Ther; 2003; 4(4):350-63. PubMed ID: 15136977
[TBL] [Abstract][Full Text] [Related]
19. Diuretic bioactivity optimization of furosemide in rats.
Laulicht B; Tripathi A; Mathiowitz E
Eur J Pharm Biopharm; 2011 Oct; 79(2):314-9. PubMed ID: 21571067
[TBL] [Abstract][Full Text] [Related]
20. Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
Bae SK; Kim YC; Lee JK; Kwon JW; Yoo M; Lee I; Lee MG
Biopharm Drug Dispos; 2006 Apr; 27(3):147-56. PubMed ID: 16408258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
